
To examine medication dosing patterns of zzso and zzso among patients with zzso 

From a large US administrative claims database, commercially insured zzso patients aged zzso who initiated zzso or zzso in 2006 were zzso zzso was defined as a zzso medication zzso with the dispense date of the first initiation as the index zzso All patients selected had continuous enrollment over the 12-month zzso and zzso zzso and were classified into the zzso or zzso zzso based on their index zzso zzso daily dose, average daily dose over the 12-month zzso period, mean and median daily doses and daily costs of each of the first 12 prescriptions were examined for both the zzso and zzso zzso 

Both the zzso zzso zzso zzso and zzso zzso zzso zzso zzso had a mean age of 50 years zzso age: 52 zzso zzso The average initial daily dose was zzso zzso for zzso and zzso zzso for zzso Over the 12-month zzso period, the average daily dose per patient was zzso zzso for zzso and zzso zzso for zzso The average daily doses for the first 12 zzso prescriptions ranged zzso zzso with the mean daily costs between zzso and zzso For the first 12 zzso prescriptions, the average daily dose increased from zzso zzso to zzso zzso while the average daily costs ranged between zzso 

Among patients with fibromyalgia, zzso and zzso initiators had different dosing zzso The average daily dose for zzso was relatively stable over time, while zzso patients had significant dose increase over the 12-month zzso zzso 

